Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis: A Randomized Controlled Trial
Background and Objective. The aim of this study was to compare the effect of autologous bone marrow-derived chondrocytes (ABMDCs) with pharmacological management of osteoarthritis of knee (OAK) and assess the benefit of the two in the improvement of pain relief, functional betterment, and quality of...
Guardado en:
Autores principales: | Mir Sadat-Ali, Abdallah S. AlOmran, Sulaiman A. AlMousa, Hasan N. AlSayed, Khalid W. AlTabash, Mohammed Q. Azam, Tarek M. Hegazi, Sadananda Acharya |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96c435dec75649b7b607cc235c8bf402 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stem-cell therapy for ovariectomy-induced osteoporosis in rats: a comparison of three treatment modalities
por: Sadat-Ali M, et al.
Publicado: (2019) -
Autologous bone marrow cell therapy for peripheral arterial disease
por: Botti C, et al.
Publicado: (2012) -
Tert-butylhydroquinone attenuates osteoarthritis by protecting chondrocytes and inhibiting macrophage polarization
por: Hua Zhang, et al.
Publicado: (2021) -
LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis
por: Manoj Arra, et al.
Publicado: (2020) -
Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3
por: Yasuhito Yahara, et al.
Publicado: (2016)